Open Access

An optimized high-performance liquid chromatography (HPLC) method for benzoylmesaconine determination in Radix Aconiti Lateralis Preparata (Fuzi, aconite roots) and its products

Chinese Medicine20083:6

DOI: 10.1186/1749-8546-3-6

Received: 08 August 2006

Accepted: 30 May 2008

Published: 30 May 2008

Abstract

Background

Benzoylmesaconine (BMA) is the main Aconitum alkaloid in Radix Aconiti Lateralis Preparata (Fuzi, aconite roots) with potent pharmacological activities, such as analgesia and anti-inflammation. The present study developed a simple and reliable method using BMA as a marker compound for the quality control of processed aconite roots and their products.

Methods

After extraction, a high-performance liquid chromatography (HPLC) determination of BMA was conducted on a RP-C18 column by gradient elution with acetonitrile and aqueous phase, containing 0.1% phosphoric acid adjusted with triethylamine to pH 3.0.

Results

A distinct peak profile was obtained and separation of BMA was achieved. Method validation showed that the relative standard deviations (RSDs) of the precision of BMA in all intra-day and inter-day assays were less than 1.36%, and that the average recovery rate was 96.95%. Quantitative analysis of BMA showed that the content of BMA varied significantly in processed aconite roots and their products.

Conclusion

This HPLC method using BMA as a marker compound is applicable to the quality control of processed aconite roots and their products.

Background

Plants of the genus Aconitum are widely distributed across Asia and North America. For over two thousand years, Radix Aconiti Lateralis Preparata (Fuzi, aconite roots) has been used in China to relieve joint pain and treat rheumatic diseases [1]. Studies demonstrated some pharmacological effects of aconite roots, such as analgesia and anti-inflammation [2, 3]. Processing aconite roots is necessary to remove the poisonous diester-diterpene type Aconitum alkaloids including aconitine, mesaconitine and hypaconitine. For example, before used in proprietary herbal products, the toxicity of these alkaloids can be lowered by hydrolysis into much less poisonous benzoylaconines which are the products of deacetylation of the 8β-acetoxyl [4]. Previously, we established a high-performance liquid chromatography (HPLC) method for determining these three toxic Aconitum alkaloids [5]. By comparing their peak areas, we found that benzoylmesaconine (BMA, Figure 1), one of the benzoylaconines, was more abundant than the other two alkaloids in most processed aconite roots [5]. It was reported that BMA at the dosage of 30 mg/kg (per oral) significantly increased the pain threshold in rats. Its analgesic potency was as potent as that of aconite roots at 1000 mg/kg (per oral) [6]. Recently, BMA was further shown to have specific cellular immunological activities, antiviral and antifungal activities [7], antinociceptive effects [8], and stimulating activities on cytokines secretion [9]. Due to its abundance and pharmacology, BMA was selected as a single marker compound for the evaluation of the quality of the processed aconite roots and their proprietary herbal products.
Figure 1

Chemical structure of benzoylmesaconine (BMA).

The present study developed a suitable analytical method for identification and quantification of BMA to simplify the quality control procedures. Several HPLC methods have been reported [10], none of which is efficient. For instance, the target compounds could not be efficiently separated in acetonitrile. Tetrahydrofuran (THF) was used as the organic component of the mobile phase, but THF would damage the RP-C18 column when its percentage was over 10% [10]. In our previous HPLC method, buffer with a pH value around 10 was used as mobile phase and a special RP-C18 column was required to stand such an alkaline buffer (pH > 8) [5, 11]. At the moment, gas chromatography-mass spectrometry (GC-MS) and liquid chromatography-mass spectrometry (LC-MS) methods are applicable, but both require sophisticated sample preparation, such as pre-column derivation and solid phase extraction (SPE) [1214]. In the present study, we developed a simple and reliable HPLC method for quantitative determination of BMA in processed aconite roots and their products.

Methods

Processed aconite roots and their proprietary products

Nine batches of the processed aconite roots were purchased from herbal medicine markets in Sichuan, Shanxi and Guangdong provinces in China (Table 1).
Table 1

BMA content (μg/g) in processed aconite roots (n = 2)

Samples (batch no)

Sample source

Mean (SD) (μg/g)

FZ040525-s1

Sichuan province

13.4 (0.5)

FZ040525-s2

Sichuan province

33.5 (0.1)

FZ030113-01

Shanxi province

25.3 (0.1)

FZ030616-01

Sichuan province

46.2 (1.2)

FZ030902-01

Guangdong province

10.7 (0.3)

FZ040406-01

Guangdong province

79.1 (1.0)

FZ040406-03

Guangdong province

164.0 (3.6)

FZ040406-07

Guangdong province

2.9 (0.1)

FZ040406-11

Guangdong province

4.6 (0.1)

The Chinese proprietary products containing processed aconite roots used in this study included Guifulizhong Wan (GW, Foshan Fengliaoxiang Pharmaceutical Co, Guangdong, China), Sanqisangyao Capsule (SC, Guangxi Yulin Pharmaceutical Co, Guangxi, China), Haimabushen Wan (HW, Tianjin Zhongxin Pharmaceutical Co, Tianjin, China), and Jinguishenqi Wan (JW, Tongrentang Pharmaceutical Co, Beijing, China). The main indications of these products are muscular disorders, joint pain and arthritis. Qingfuguanjieshu Capsule (QC), a new antiarthritic herbal preparation being developed in our research group [15, 16], was also used in the present study.

Chemicals and reagents

Acetonitrile was of HPLC grade (International Laboratory, USA). Twenty-eight per cent (28%) ammonia solution (AJAX Chemicals, Australia), 95% ethanol (UNI-CHEM, Hong Kong, China), chloroform (TEDIA, USA), ethyl acetate, triethylamine, 85% phosphoric acid, diethyl ether anhydrous (International Laboratory, USA) and hydrochloric acid (Merck, Germany) were of guaranteed reagent grade. Deionized water was prepared using a Millipore water purification system (Millipore Corp, USA).

The reference standard for BMA was prepared from mesaconitine (National Institute for the Control of Pharmaceutical and Biological Products, China) which was heated at 100°C in dioxane-water (1:1) for 6 hours and purified by column chromatography and crystallization [5, 11]. The identity and purity (≥ 95%) of BMA were confirmed by TLC (thin-layer chromatography), HPLC, and spectroscopy (1H-NMR and MS) [17].

HPLC conditions

An Agilent 1100 series LC system (Hewlett Packard, USA) was used in the study, which consisted of a G1311A quaternary pump, a G1322A degasser, a G1315A diode-array detector and a G1313A autosampler.

Alltima RP-C18 (ID 250 × 4.6 mm, particle size 5 μm, Alltech Associates, Inc., USA) was used as the stationary phase companied by Alltima RP-C18 guard column (ID 7.5 × 4.6 mm). Elution of the alkaloids was carried out using a gradient of acetonitrile (A) and buffer solution (B, containing 0.1% phosphoric acid and 0.1% triethylamine, adjusted to pH 3.0 with triethylamine) at a flow-rate of 1.0 ml/min. The gradient elution of the mobile phase was 13–18 % A in 0–20 min, 18–21 % A in 20–40 min, 21–22 % A in 40–45 min and 22–70 % A in 45–50 min. Detection was carried out at 240 nm with a reference wavelength of 550 nm at room temperature. The injection volume was 20 μl for all HPLC runs.

Preparation of sample solutions

Processed aconite roots were pulverized into powder, passed through a 0.45 mm sieve, and stored in a desiccator. The powder (1.5 g) was extracted with 50% ethanol three times (4.0 ml, 4.0 ml and 2.0 ml respectively and 60 min each time) by sonication (Branson 5210 Ultrasonicator, Balkowitsch Enterprises, Inc., USA) at room temperature, and then vortexed for 2 min respectively. The mixture was centrifuged for 10 min at 3000 rpm (Eppendorf 5810 Centrifuge, Scios, Inc., USA). The supernatants were combined and transferred to a 10.0 ml volumetric flask, with 50% ethanol making up the volume.

Powdered pills or contents of capsules of the proprietary products (approximately 1.0 g) were accurately weighed. Each sample was dissolved in 10 ml of HCl solution (0.05 M) by sonication for 60 min, and extracted with ethyl acetate three times (10 ml each time). The acidic aqueous solution was separated and basified with 600 μl of 28% ammonia solution and further extracted with 10 ml of mixed solvents of diethyl ether and ethyl acetate (1:1) three times by vortexing for 2 min. The resulting mixtures were centrifuged at 3000 rpm (Eppendorf 5810 Centrifuge, Scios Inc, USA) for 5 min and the combined supernatants were evaporated to dryness under air stream. The residue was dissolved in 1.0 ml of HCl solution (0.01 M) by sonication for 1 min.

Preparation of standard solutions

BMA was accurately weighed and dissolved in HCl solution (0.01 M) to produce a stock standard solution at a final concentration of 0.4084 mg/ml. This stock solution was used to prepare standard solutions for method validation and calibration curves. The standard solutions were stored at 4°C and remained stable for at least one month. Calibration curves were established at seven concentration (μg/ml) points of 4.08, 10.21, 20.42, 40.84, 81.68, 122.52 and 204.20 respectively. For recovery test, a standard solution was prepared at a concentration of 12.25 μg/ml.

Validation of the HPLC method

Precision

Expressed as relative standard deviations (RSDs), precision was evaluated by HPLC runs with standard solutions at three concentrations under the optimal condition five times in one day for intra-day variation test and twice a day on three consecutive days for inter-day variation test.

Repeatability

Six aliquots of QC were conducted for repeatability test. The processing of the aliquots followed the same method described in the section of preparation of sample solutions. The RSDs of the six aliquots were calculated for evaluation of repeatability.

Recovery

HCl solution (10 ml, 0.05 M) was added to accurately weighted QC (approximately 0.1 g) in which the content of BMA was known. The sample solution was spiked with 1000 μl of the standard solution of BMA for recovery test. The processing of the prepared samples (n = 6) followed the method described in the section of preparation of sample solutions.

Statistical analysis

Data analysis, including calculation of standard deviation (SD) and linear regression, was conducted using Excel 2003 (Microsoft, USA). P values less than 0.05 were considered as statistically significant.

Results and discussion

Optimization of HPLC conditions

The use of phosphoric acid (0.1 %) with triethylamine as the mobile phase produced better symmetry of the peak in the chromatogram. A gradient elution program was developed to isolate BMA and to determine the content of BMA in the proprietary products. Figure 2 shows a chromatogram of BMA (35 μg/ml) in standard solution. Figure 3 shows a chromatogram (detection at 240 nm) of BMA in 50 % ethanol extract of processed aconite roots. The results indicate that the retention time (43.5 min) of BMA in processed aconite roots (Figure 3) and in QC preparation (Figure 4) was consistent with that of BMA in standard solution (Figure 2).
Figure 2

An HPLC chromatogram of BMA standard solution.

Figure 3

An HPLC chromatogram of BMA in processed aconite roots (batch no 040406-01).

Figure 4

An HPLC chromatogram of BMA in QC.

By adjusting the triethylamine content to obtain the pH values from 2.3 to 5.6, we investigated the pH dependence of the retention time. The results show BMA retention time remained relatively stable in the range of 42–44 min as pH value increased (Figure 5). Due to a long elution time and drifting baseline at pH values below 2.6 and above 4.9 respectively, the HPLC runs in the present study were carried out at pH 3.0 for best effect.
Figure 5

Relation of pH and the retention time of BMA.

Optimization of extraction conditions

Common extracting solvents including water and aqueous ethanol (95 %, 75 %, 50 % and 25 %) were evaluated for their efficiency in extracting BMA from processed aconite roots. Since BMA is an alkaloid, an acidic extraction solvent (0.01 M HCl) was also tested. The results show that the extraction efficiency of these solvents was in the following order: 50 % ethanol > 25% ethanol > 0.01 M HCl > 75 % ethanol > 95 % ethanol. For highest efficiency, 50 % ethanol was selected for extracting BMA in processed aconite roots in the present study (Table 2).
Table 2

Efficiency of different solvents in extracting the content of BMA (μg/g) from processed aconite roots (n = 2)

Solvents

Mean (SD) (μg/g)

RSD (%)

0.01 M HCl

20.8 (0.3)

1.24%

25% ethanol

22.7 (0.0)

0.10%

50% ethanol

25.3 (0.1)

0.45%

75% ethanol

14.8 (0.3)

0.18%

95% ethanol

0.55 (0.06)

10.98%

Note: Sample FZ030113-01 was used in this experiment.

As a single-step extraction with 50 % ethanol contained many impurities, we developed a multi-step extraction to remove some non-alkaloid components in the extracts. Powdered proprietary products were dissolved in 10 ml of HCl solution (0.05 M) by sonication for 60 min, which were subsequently extracted with ethyl acetate for three times (10 ml each time). The acidic aqueous solutions were then basified with 600 μl of 28 % ammonia solution and further extracted with 10 ml of mixed solvents of diethyl ether and ethyl acetate (1:1) for three times. The recovery rate of BMA was 90.64% (SD 0.58%) when diethyl ether was the extraction solvent. The recovery rate was nearly perfect when ethyl acetate was the extraction solvent; however, there was a small interference peak at the retention time of 43 min. Thus, a mixed solvent of diethyl ether and ethyl acetate (1:1) was used, whereby the recovery rate was 96.95% (SD 1.01%) and no interference peak was observed.

Validation of the HPLC method

The BMA peaks in processed aconite roots and in their proprietary products were identified through comparison of the retention times and UV spectra with those of the reference standards. Peak purity was confirmed by data from a photodiode array detector (DAD). Furthermore, a comparative study was carried out with QC samples and QC without processed aconite roots (negative control). There is no peak corresponding to BMA in the chromatogram of the negative control (Figure 6).
Figure 6

An HPLC chromatogram of QC product without processed aconite roots (negative control).

The linearity of the BMA concentrations (μg/ml) versus peak areas was investigated in the range of 4.08–204.20 μg/ml; the result is expressed as the value of the coefficient of determination (R2). The following equation was obtained: Y = 18.518X + 5.651 (R2 = 0.9998, P < 0.001).

The limit of detection, defined as the amount of the compounds needed to produce a signal (S) at least three times larger than noise (N), was determined to be 8 ng for BMA with an injection volume of 20 μl.

The precision of the intra-day (five times per day) and inter-day (twice a day for three consecutive days) data was indicated by RSDs which were less than 1.36% for BMA at three concentrations (Table 3). These results suggest that BMA is stable in acidic solution (0.01 M HCl). The accuracy was determined by back calculation of precision samples at three concentrations against a calibration curve prepared each day.
Table 3

Precision of the intra-day and inter-day measurements

Conc. μg/ml

Intra-day a

Inter-day b

Peak areas Mean (SD)

RSD %

Precision %

Peak areas Mean (SD)

RSD %

Precision %

Low (4.08)

63.0 (0.8)

1.36

95.90%

65.3 (0.5)

0.88

95.08%

Mid (20.42)

303.1 (0.4)

0.15

95.48%

309.9 (1.8)

0.60

95.80%

High (122.52)

1870.0 (7.5)

0.39

97.55%

1890.0 (17.8)

0.95

98.59%

Note: a: n = 5; b: n = 6 (twice a day for three consecutive days).

The RSDs of the repeatability test were less than 0.29% for BMA at 132.8 μg/g (SD 0.4 μg/g) in the QC samples (n = 6). The average recovery rate obtained was 96.95% (SD 1.01%) with RSDs of 0.01% (n = 6). This chromatographic system is suitable for quantitative determination of BMA in processed aconite roots and their proprietary products.

Quantitative determination of BMA

The content of BMA in the five proprietary products, and nine batches of processed aconite roots were determined using the established HPLC method described above. The content of BMA (Tables 1 and 4) was calculated with the regression equations obtained from the calibration curves.
Table 4

BMA content (μg/g) in five herbal proprietary products containing processed aconite roots (n = 2)

Product

Batch no

Dosage (g/day)

Mean (SD) (μg/g)

GW

0405005

18

6.9 (0.1)

SC

20030801

2.25

245.0 (0.7)

HW

030769

5.4

58.0 (0.2)

JW

3030904

10

6.0 (0.0)

QC

20040901

8.5

132.8 (0.4)

Note: GW: Guifulizhong Wan, SC: Sanqisangyao Capsule, HW: Haimabushen Wan, JW: Jinguishenqi Wan, QC: Qingfuguanjieshu Capsule

Significant variations in terms of BMA content were found among different batches of processed aconite roots and among different proprietary products (Tables 1 and 4). Differences in species, places of origin, processing methods of the raw materials and pharmaceutical manufacturing processes may all contribute to the variations.

As herbal products containing processed aconite roots are increasingly used for anti-inflammation and analgesia, simple and reliable methods for quality control of these products are urgently needed. It was reported that BMA was effective in anti-inflammation and analgesia in animals [2, 6]. Thus, BMA was selected as a marker compound to assess the quality of processed aconite roots and their proprietary products.

In the present study, extraction method was optimized. Results from the recovery test show that the use of two solvents is better than that of a single solvent in preparing samples of proprietary products.

In the analysis of Aconitum alkaloids using a reversed phase C18 HPLC column, tailing peaks are usually caused by the retention effects of free silanol groupings. Instead of using THF as an organic solvent or basic buffer in the mobile phase, we used triethylamine to improve separation and peak shapes. Moreover, this HPLC method should be easily repeated in other labs. The present study also indicates that the retention volumes of BMA remained relatively unchanged over an acidic pH region (Figure 5).

Conclusion

Method validation data indicate that the developed HPLC method as described in this paper is reliable, reproducible and accurate for the determination of BMA in processed aconite roots and their products. The results also show that the content of BMA varied significantly in different batches of the processed aconite roots including five proprietary products. This method is suitable for routine assessment of the quality of processed aconite roots and their products.

Abbreviations

BMA: 

benzoylmesaconine

DAD: 

photodiode array detector

GC-MS: 

gas chromatography-mass spectrometry

HPLC: 

high-performance liquid chromatography

LC-MS: 

liquid chromatography-mass spectrometry

RSDs: 

relative standard deviations

SD: 

standard deviation

SPE: 

solid phase extraction

THF: 

tetrahydrofuran

Declarations

Acknowledgements

This work was funded by the Hong Kong Jockey Club Charities Trust.

Authors’ Affiliations

(1)
School of Chinese Medicine, Hong Kong Baptist University
(2)
Hong Kong Jockey Club Institute of Chinese Medicine

References

  1. Bisset NG: Arrow poisons in China (Part II): Aconitum – botany, chemistry, and pharmacology. J Ethnopharmacol. 1981, 4: 247-336. 10.1016/0378-8741(81)90001-5.View ArticlePubMedGoogle Scholar
  2. Hikino H, Konno C, Takata H, Yamada Y, Yamada C, Ohizumi Y, Sugio K, Fujimura H: Anti-inflammatory principles of Aconitum roots. J Pharmacobiodyn. 1980, 3 (10): 514-525.View ArticlePubMedGoogle Scholar
  3. Gutser UT, Friese J, Heubach JF, Matthiesen T, Selve N, Gleitz J: Mode of antinociceptive and toxic action of alkaloids of Aconitum sepc. Naunyn Schmiedebergs Arch Pharmacol. 1998, 357: 39-48. 10.1007/PL00005136.View ArticlePubMedGoogle Scholar
  4. Xu Q, Zhang F, Xiao HB, Liang XM, Kettrup A: Study on detoxification of main alkaloids in Aconitum by high performance liquid chromatography -atmospheric pressure chemical ionization mass spectrometry. Fresenius Environ Bull. 2005, 14: 194-198.Google Scholar
  5. Jiang ZH, Xie Y, Zhou H, Liu ZQ, Wong YF, Cai X, Xu HX, Liu L: Quantication of Aconitum alkaloids in aconite roots by a modified RP-HPLC method. Phytochem Anal. 2005, 16: 415-421. 10.1002/pca.861.View ArticlePubMedGoogle Scholar
  6. Suzuki Y, Hayakawa Y, Oyama T, Isono T, Ohmiya Y, Ikeda Y, Asami A, Noguchi M: Analgesic effect of benzoylmesaconine. Nippon Yakurigaku Zasshi. 1993, 102: 399-404.View ArticlePubMedGoogle Scholar
  7. Kobayashi M, Mori K, Kobayashi H, Pollard RB, Suzuki F: The regulation of burn-associated infections with herpes simplex virus type 1 or Candida albicans by a non-toxic aconitine-hydrolyzed, benzoylmesaconine. Part 1: antiviral and anti-fungal activities in thermally injured mice. Immun Cell Bio. 1998, 76 (3): 202-208. 10.1046/j.1440-1711.1998.00735.x.View ArticleGoogle Scholar
  8. Suzuki Y, Oyama T, Ishige A, Isono T, Asami A, Ikeda Y, Noguchi M, Ohmiya Y: Antinociceptive mechanism of the aconitine alkaloids mesaconitine and benzoylmesaconine. Planta Med. 1994, 60: 391-394. 10.1055/s-2006-959516.View ArticlePubMedGoogle Scholar
  9. Kobayashi M, Takahashi H, Herndon DN, Pollard RB, Suzuki F: Soluble IL-4 receptor improves the skin-graft-associated cytomegalovirus infection in thermally injured mice. Burns. 2003, 29: 37-42. 10.1016/S0305-4179(02)00248-6.View ArticlePubMedGoogle Scholar
  10. Hikino H, Konno C: Determination of aconitine alkaloids by high-performance liquid chromatography. J Chromatogr. 1981, 211: 123-128. 10.1016/S0021-9673(00)81180-2.View ArticleGoogle Scholar
  11. Xie Y, Jiang ZH, Zhou H, Xu HX, Liu L: Simultaneous determination of six Aconitum alkaloids in proprietary Chinese medicines by high-performance liquid chromatography. J Chromatogr A. 2005, 1093: 195-203. 10.1016/j.chroma.2005.07.071.View ArticlePubMedGoogle Scholar
  12. Ohta H, Seto Y, Tsunoda N, Takahashi Y, Matsuura K, Ogasawara K: Determiantion of Aconitum alkaloids in blood and urine samples. II. Capillary liquid chromatographic-frit fast atom bombardment mass spectrometric analysis. J Chromatogr B. 1998, 714: 215-221. 10.1016/S0378-4347(98)00241-2.View ArticleGoogle Scholar
  13. Ohta H, Seto Y, Tsunoda N: Determination of Aconitum alkaloids in blood and urine samples. I. High performance liquid chromatographic separation, solid-phase extraction and mass spectrometric confirmation. J Chromatogr B. 1997, 691: 351-356. 10.1016/S0378-4347(96)00471-9.View ArticleGoogle Scholar
  14. Ito K, Satoshi T, Funayama M, Mizugaki M: Quantitative analysis of Aconitum alkaloids in the urine and serum of a male attempting suicide by oral intake of aconite extract. J Anal Toxicol. 2000, 24: 348-340.View ArticlePubMedGoogle Scholar
  15. Cai X, Zhou H, Wong YF, Xie Y, Liu ZQ, Jiang ZH, Bian ZX, Xu HX, Liu L: Suppressive effects of QFGJS, a preparation from an anti-arthritic herbal formula, on rat experimental adjuvant-induced arthritis. Biochem Biophys Res Commun. 2005, 337: 586-594. 10.1016/j.bbrc.2005.09.083.View ArticlePubMedGoogle Scholar
  16. Zhou H, Wong YF, Cai X, Liu ZQ, Jiang ZH, Bian ZX, Xu HX, Liu L: Suppressive Effects of JCICM-6, the Extract of an Anti-arthritic Herbal Formula, on the Experimental Inflammatory and Nociceptive Models in Rodents. Biol Pharm Bull. 2006, 29: 253-260. 10.1248/bpb.29.253.View ArticlePubMedGoogle Scholar
  17. Pelletier SW: Alkaloids, Chemical and Biological Perspectives. 1991, New York: Springer-Verlag, 7: 390-397.View ArticleGoogle Scholar

Copyright

© Xie et al; licensee BioMed Central Ltd. 2008

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Advertisement